PWMS News Search Results

Back to
   Back to PeopleWithMS NewsWire 

July 2, 2007 Off the Wire . . .



PeopleWithMS - NewsWire

UCSF Trial of Low Dose Naltrexone (LDN) Still Enrolling

This study is taking place at UCSF (in San Francisco).

If you participate, you will be randomly assigned to one of two groups. Both groups will receive LDN for eight weeks and a placebo for eight weeks. One of the groups will receive the LDN first, and the other group will receive it last. Neither you nor your doctor will know which group you are in until after the study is complete.

If you enroll in this study, you must continue to take any MS medications that you’re already taking. For eight weeks, you will take either the LDN or the inactive placebo every night before going to bed between the hours of 9:00 PM to 3:00 AM. You will take neither drug for the ninth week. Finally, you will take the other drug for the last eight weeks of the trial. You will be asked to answer a questionnaire (called “MSQLI54”) at the baseline and at weeks 8 and 17.

To request additional information, phone (415) 514-3815.

E-Mail the NewsWire - Handpainted and Customized Canes
 with any news items you discover 

©copyright 2003